Pyrazoles as NMDA NR2B receptor inhibitors and their preparation

Janssen Pharmaceuticals, Inc. 2016. Pyrazoles as NMDA NR2B receptor inhibitors and their preparation. WO2016025918A1. [Patent].

Full text not available from this repository.

Abstract

The invention relates to pyrazole derivatives which are NMDA NR2B receptor inhibitors, useful in treating central o nervous system diseases.

Item Type:	Patent
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Subjects:	R Medicine > R Medicine (General)
Last Modified:	24 Oct 2022 08:43
URI:	https://orca.cardiff.ac.uk/id/eprint/118503

Actions (repository staff only)

Edit Item